Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: A causal relationship?

European Journal of Paediatric Neurology

Volumn 11, Issue 6, 2007, Pages 358-361

  Attilakos, Achilleas ^a   Garoufi, Anastasia ^a   Voudris, Konstantinos ^b   Mastroyianni, Sotiria ^b   Fotinou, Aspasia ^b   Papadimitriou, Dimitrios T ^a   Gavalakis, Nikolaos ^a   Prassouli, Alexia ^a   Katsarou, Eustathia ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Carbamazepine monotherapy; Children; Epilepsy; Low density lipoprotein cholesterol; Thyroid

Indexed keywords

CARBAMAZEPINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; EPILEPSY; FEMALE; HUMANS; IMMUNOASSAY; MALE; STATISTICS AS TOPIC; THYROID DISEASES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 35048820593     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2007.03.002     Document Type: Article

References (21)

1. Franzoni E., Govoni M., D'Addato S., et al. Total cholesterol, high-density lipoprotein cholesterol and triglycerides in children receiving antiepileptic drugs. Epilepsia 33 (1992) 932-935
2. Sozuer D.T., Atakil D., Dogu O., Baybas S., and Arpaci B. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 156 (1997) 565-567
3. Castro-Gago M., Novo-Rodriguez M.I., Blanco-Barca M.O., et al. Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital. J Child Neurol 21 (2006) 48-53
4. Eiris J., Novo-Rodriguez M.I., Del Rio M., et al. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res 41 (2000) 1-7
5. Sonmez F.M., Demir E., Orem A., et al. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J Child Neurol 21 (2006) 70-74
6. Isojarvi J.I., Pakarinen A.J., and Myllyla V.V. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 46 (1989) 1175-1178
7. Verrotti A., Basciani F., Morresi S., Morgese G., and Chiarelli F. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol 25 (2001) 43-46
8. Vainionpaa L.K., Mikkonen K., Rattya J., et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 45 (2004) 197-203
9. Hegedus L., Hansen J.M., Luhdorf K., et al. Increased frequency of goitre in epileptic patients on long-term phenytoin or carbamazepine treatment. Clin Endocrinol (Oxf) 23 (1985) 423-429
10. Eiris-Punal J., Del Rio-Garma M., Del Rio-Garma M.C., et al. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 40 (1999) 1761-1766
11. Voudris K.A., Attilakos A., Katsarou E., et al. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Res 70 (2006) 211-217
12. De Luca F., Arrigo T., Pandullo E., et al. Changes in thyroid function tests induced by 2 months carbamazepine treatment in L-thyroxine-substituted hypothyroid children. Eur J Pediatr 145 (1986) 77-79
13. Connell J.M., Rapeport W.G., Gordon S., and Brodie M.J. Changes in circulating thyroid hormones during short hepatic enzyme induction with carbamazepine. Eur J Clin Pharmacol 26 (1984) 453-456
14. Liewendahl K., Majuri H., and Helenius T. Thyroid function tests in patients on long-term treatment with varius anriconvulsant drugs. Clin Endocrinol 8 (1978) 185-191
15. Bongu D., Sachdev J., and Kabadi U.M. Effects of carbamazepine on the hypothalamic-pituitary-thyroid axis. Endocr Pract 5 (1999) 239-244
16. Alexopoulou O., Beguin C., De Nayer P., and Maiter D. Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150 (2004) 1-8
17. Ferretti E., Persani L., Jaffrain-Rea M.L., et al. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84 (1999) 924-929
18. Rose S.R. Cranial irradiation and central hypothyroidism. Trends Endocrinol Metab 12 (2001) 97-104
19. Pearce E.N. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep 6 (2004) 451-456
20. Iqbal A., Jorde R., and Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med 260 (2006) 53-61
21. Hamed S.A., Hamed E.A., Kandil M.R., et al. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 66 (2005) 173-183